linagliptin is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --

General

Pronunciation:
lin-a-glip-tin


Trade Name(s)

  • Tradjenta
  • Trajenta Canadian Tradename

Ther. Class.
antidiabetics

Pharm. Class.
dipeptidyl peptidase-4 (DDP-4) inhibitors
enzyme inhibitors

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - linagliptin ID - 109602 A1 - Quiring,Courtney, AU - Sanoski,Cynthia A, AU - Vallerand,April Hazard, BT - Davis's Drug Guide UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109602/all/linagliptin PB - F.A. Davis Company ET - 16 DB - Medicine Central DP - Unbound Medicine ER -